← back to search

J.C. Aschenbrenner

University of Cape Town · ZA
Area of research
Biomedical Engineering · Materials Chemistry
Research interest
Research interests include Protease, Virology, Fragment (logic), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), and 2019-20 coronavirus outbreak.
h-index
citations
178
works
3
NIH funding
primary concept
email

Recent publications

Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors
Nature Communications 2025cited by 6position: middledoi
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 3position: middledoi
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors
Science 2023cited by 169position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2024–2024)Max Winokan · University of Surrey1 papers (2024–2024)Martin Walsh · California Institute for Regenerative Medicine1 papers (2024–2024)Matteo P. Ferla · Centre for Human Genetics1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024)Eleanor Williams · University of Oxford1 papers (2024–2024) · 1 papers (2024–2024)Blake Balcomb · University of Kansas1 papers (2024–2024) · 1 papers (2024–2024)Charline Giroud · Children's Healthcare of Atlanta1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024)Xiaomin Ni · Discovery Centre1 papers (2024–2024)L. Koekemoer · University of Cape Town1 papers (2024–2024) · 1 papers (2024–2024)Ryan Lithgo · University of Nottingham1 papers (2024–2024)